JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Aktien・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Geschlossen

1.21 -0.82

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.19

Max

1.22

Schlüsselkennzahlen
By Trading Economics
Einkommen	2.7M -24M
EPS	-0.354
Angestellte	49
EBITDA	-5.3M -28M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+122.5% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-6.2M 75M
Vorheriger Eröffnungskurs	2.03
Vorheriger Schlusskurs	1.21

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

1.43 / 1.6 Unterstützung & Widerstand

Pliant Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Mai 2026, 23:43 UTC

Wichtige Nachrichtenereignisse

New Zealand's Unemployment Rate Falls in 1Q

5. Mai 2026, 23:20 UTC

Heiße Aktien

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

5. Mai 2026, 21:48 UTC

Ergebnisse

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

5. Mai 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

6. Mai 2026, 00:00 UTC

Market Talk

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

5. Mai 2026, 23:39 UTC

Market Talk

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

5. Mai 2026, 22:26 UTC

Market Talk

AMD Data-Center Business Continues to Surge -- Market Talk

5. Mai 2026, 22:20 UTC

Market Talk

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

5. Mai 2026, 22:08 UTC

Ergebnisse

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

5. Mai 2026, 22:07 UTC

Ergebnisse

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Adj EPS $1.09 >PAAS

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Rev $1.2B >PAAS

5. Mai 2026, 21:42 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:38 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:30 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:29 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:26 UTC

Ergebnisse

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q EPS 39c >ALC.EB

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q Rev $2.71B >ALC.EB

5. Mai 2026, 21:24 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:18 UTC

Ergebnisse

Mistras Backs 2026 Rev $730M-$750M >MG

5. Mai 2026, 21:17 UTC

Ergebnisse

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

5. Mai 2026, 21:15 UTC

Ergebnisse

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

5. Mai 2026, 21:12 UTC

Ergebnisse

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

5. Mai 2026, 21:11 UTC

Ergebnisse

SSR Mining 1Q Rev $581.8M >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q Adj EPS $1.15 >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q EPS $1.16 >SSRM

5. Mai 2026, 21:08 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:01 UTC

Ergebnisse

Intact Financial 1Q EPS C$4.12 >IFC.T

5. Mai 2026, 21:01 UTC

Heiße Aktien

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

Peer-Vergleich

Kursveränderung

Pliant Therapeutics Inc Prognose

Kursziel

By TipRanks

122.5% Vorteil

12-Monats-Prognose

Durchschnitt 2.67 USD 122.5%

Hoch 3 USD

Tief 2 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pliant Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pliant Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

1.43 / 1.6Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

There is one bearish event.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.